Cargando…

Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases

PURPOSE: To assess the effects of different beam starting phases on dosimetric variations in the clinical target volume (CTV) and organs at risk (OARs), and to identify the relationship between plan complexity and the dosimetric impact of interplay effects in volumetric‐modulated arc therapy (VMAT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Makoto, Nakamura, Mitsuhiro, Mukumoto, Nobutaka, Goto, Yoko, Ishihara, Yoshitomo, Nakata, Manabu, Sugimoto, Naozo, Mizowaki, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806466/
https://www.ncbi.nlm.nih.gov/pubmed/31539194
http://dx.doi.org/10.1002/acm2.12720
_version_ 1783461633390018560
author Sasaki, Makoto
Nakamura, Mitsuhiro
Mukumoto, Nobutaka
Goto, Yoko
Ishihara, Yoshitomo
Nakata, Manabu
Sugimoto, Naozo
Mizowaki, Takashi
author_facet Sasaki, Makoto
Nakamura, Mitsuhiro
Mukumoto, Nobutaka
Goto, Yoko
Ishihara, Yoshitomo
Nakata, Manabu
Sugimoto, Naozo
Mizowaki, Takashi
author_sort Sasaki, Makoto
collection PubMed
description PURPOSE: To assess the effects of different beam starting phases on dosimetric variations in the clinical target volume (CTV) and organs at risk (OARs), and to identify the relationship between plan complexity and the dosimetric impact of interplay effects in volumetric‐modulated arc therapy (VMAT) plans for pancreatic cancer. METHODS: Single and double full‐arc VMAT plans were generated for 11 patients. A dose of 50.4 Gy in 28 fractions was prescribed to cover 50% of the planning target volume. Patient‐specific Digital Imaging and Communications in Medicine–Radiation Therapy plan files were divided into 10 files based on the respiratory phases in four‐dimensional computed tomography (4DCT) simulations. The phase‐divided VMAT plans were calculated in consideration of the beam starting phase for each arc and were then combined in the mid‐ventilation phase of 4DCT (4D plans). The dose‐volumetric parameters were compared with the calculated dose distributions without consideration of the interplay effects (3D plans). Additionally, relationships among plan parameters such as modulation complexity scores, monitor units (MUs), and dose‐volumetric parameters were evaluated. RESULTS: Dosimetric differences in the median values associated with different beam starting phases were within ± 1.0% and ± 0.2% for the CTV and ± 0.5% and ± 0.9% for the OARs during single and double full‐arc VMAT, respectively. Significant differences caused by variations in the beam starting phases were observed only for the dose‐volumetric parameters of the CTV during single full‐arc VMAT (P < 0.05), associated with moderate or strong correlations between the MUs and the dosimetric differences between the 4D and 3D plans. CONCLUSIONS: The beam starting phase affected CTV dosimetric variations of single full‐arc VMAT. The use of double full‐arc VMAT mitigated this problem. However, variation in the dose delivered to OARs was not dependent on the beam starting phase, even for single full‐arc VMAT.
format Online
Article
Text
id pubmed-6806466
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68064662019-10-28 Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases Sasaki, Makoto Nakamura, Mitsuhiro Mukumoto, Nobutaka Goto, Yoko Ishihara, Yoshitomo Nakata, Manabu Sugimoto, Naozo Mizowaki, Takashi J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: To assess the effects of different beam starting phases on dosimetric variations in the clinical target volume (CTV) and organs at risk (OARs), and to identify the relationship between plan complexity and the dosimetric impact of interplay effects in volumetric‐modulated arc therapy (VMAT) plans for pancreatic cancer. METHODS: Single and double full‐arc VMAT plans were generated for 11 patients. A dose of 50.4 Gy in 28 fractions was prescribed to cover 50% of the planning target volume. Patient‐specific Digital Imaging and Communications in Medicine–Radiation Therapy plan files were divided into 10 files based on the respiratory phases in four‐dimensional computed tomography (4DCT) simulations. The phase‐divided VMAT plans were calculated in consideration of the beam starting phase for each arc and were then combined in the mid‐ventilation phase of 4DCT (4D plans). The dose‐volumetric parameters were compared with the calculated dose distributions without consideration of the interplay effects (3D plans). Additionally, relationships among plan parameters such as modulation complexity scores, monitor units (MUs), and dose‐volumetric parameters were evaluated. RESULTS: Dosimetric differences in the median values associated with different beam starting phases were within ± 1.0% and ± 0.2% for the CTV and ± 0.5% and ± 0.9% for the OARs during single and double full‐arc VMAT, respectively. Significant differences caused by variations in the beam starting phases were observed only for the dose‐volumetric parameters of the CTV during single full‐arc VMAT (P < 0.05), associated with moderate or strong correlations between the MUs and the dosimetric differences between the 4D and 3D plans. CONCLUSIONS: The beam starting phase affected CTV dosimetric variations of single full‐arc VMAT. The use of double full‐arc VMAT mitigated this problem. However, variation in the dose delivered to OARs was not dependent on the beam starting phase, even for single full‐arc VMAT. John Wiley and Sons Inc. 2019-09-20 /pmc/articles/PMC6806466/ /pubmed/31539194 http://dx.doi.org/10.1002/acm2.12720 Text en © 2019 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Sasaki, Makoto
Nakamura, Mitsuhiro
Mukumoto, Nobutaka
Goto, Yoko
Ishihara, Yoshitomo
Nakata, Manabu
Sugimoto, Naozo
Mizowaki, Takashi
Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases
title Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases
title_full Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases
title_fullStr Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases
title_full_unstemmed Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases
title_short Variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases
title_sort variation in accumulated dose of volumetric‐modulated arc therapy for pancreatic cancer due to different beam starting phases
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806466/
https://www.ncbi.nlm.nih.gov/pubmed/31539194
http://dx.doi.org/10.1002/acm2.12720
work_keys_str_mv AT sasakimakoto variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases
AT nakamuramitsuhiro variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases
AT mukumotonobutaka variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases
AT gotoyoko variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases
AT ishiharayoshitomo variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases
AT nakatamanabu variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases
AT sugimotonaozo variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases
AT mizowakitakashi variationinaccumulateddoseofvolumetricmodulatedarctherapyforpancreaticcancerduetodifferentbeamstartingphases